Competition for biotech and pharma employment picked up year over year and remains strong, according to BioSpace data. A survey late last year showed that 64% of employed/contract and 96% of ...
As supply chain vulnerabilities intensify and competition accelerates, the cost of this underutilization could risk India's ...
Investing.com on MSN
Amneal Pharmaceuticals' SWOT analysis: generic drug maker's stock poised for growth
Amneal Pharmaceuticals (NYSE:NASDAQ:AMRX), a commercial-stage biopharmaceutical company with a market capitalization of $2.53 billion, has been positioning itself for a new phase of multi-year growth ...
On Thursday, Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH) reported fourth-quarter adjusted EPS of 92 cents, up from 88 cents a year ago, but missing the consensus of 94 cents. Amphastar is a ...
WENZHOU, ZHEJIANG PROVINCE, CHINA, January 19, 2026 /EINPresswire.com/ -- As the global pharmaceutical and healthcare ...
Industry reports the Saudi pharmaceutical CDMO market is expected to increase from USD $1.62 billion in 2024 to USD $2.24 billion by 2030 at a compound annual growth rate (CAGR) of 5.45%, reflecting ...
New Delhi gains a tariff advantage over China and Bangladesh as US President Donald Trump cuts India tariffs to 18 per cent ...
In a report released yesterday, Alec Stranahan from Bank of America Securities reiterated a Buy rating on Agios Pharma (AGIO – Research Report), with a price target of $60.00. Pick the best stocks and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results